The concern of generic rivalry has consistently loomed around copyright’s iconic click here drug, Sildenafil, triggering questions about the outlook of similar drug portfolios. While first years saw impressive profits, the intellectual property expiration has opened the door for less expensive substitutes, likely reducing revenue and creating a g